0001062993-21-001910.txt : 20210224
0001062993-21-001910.hdr.sgml : 20210224
20210224130508
ACCESSION NUMBER: 0001062993-21-001910
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210224
DATE AS OF CHANGE: 20210224
EFFECTIVENESS DATE: 20210224
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Small Pharma Ltd.
CENTRAL INDEX KEY: 0001847727
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-390363
FILM NUMBER: 21670737
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR, 6-8 BONHILL STREET
CITY: LONDON
STATE: X0
ZIP: EC2A 4BX
BUSINESS PHONE: 44 (0)7812 121944
MAIL ADDRESS:
STREET 1: 3RD FLOOR, 6-8 BONHILL STREET
CITY: LONDON
STATE: X0
ZIP: EC2A 4BX
D
1
primary_doc.xml
X0708
D
LIVE
0001847727
Small Pharma Ltd.
3RD FLOOR, 6-8 BONHILL STREET
LONDON
X0
UNITED KINGDOM
EC2A 4BX
44 (0)7812 121944
UNITED KINGDOM
None
None
Corporation
true
Peter
Rands
3rd Floor, 6-8 Bonhill Street
London
X0
UNITED KINGDOM
EC2A 4BX
Executive Officer
Director
Marie Claire
Layzell
3rd Floor, 6-8 Bonhill Street
London
X0
UNITED KINGDOM
EC2A 4BX
Executive Officer
Director
Khalid
Howladar
3rd Floor, 6-8 Bonhill Street
London
X0
UNITED KINGDOM
EC2A 4BX
Director
George
Tziras
3rd Floor, 6-8 Bonhill Street
London
X0
UNITED KINGDOM
EC2A 4BX
Director
Carol
Routledge
3rd Floor, 6-8 Bonhill Street
London
X0
UNITED KINGDOM
EC2A 4BX
Executive Officer
Other
Decline to Disclose
- 06b
false
2021-01-25
false
true
true
true
true
Convertible loan notes bearing 6% interest per annum maturing on July 1, 2021. Each note is convertible into shares of the Issuer prior to the occurrence of certain events.
true
Convertible loan notes are convertible into securities of the Issuer for no additional consideration prior to the closing of a merger transaction with Unilock Capital Corp.
0
1864613
1864613
0
U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7851 reported on January 25, 2021.
false
4
0
0
0
false
Small Pharma Ltd.
/s/ Peter Rands
Peter Rands
Chief Executive Officer
2021-02-24